|
|
Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
Blood is approximately twice as thick as water because of the cells and other components found in it.
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.
The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").